Serum Levels of the Proinflammatory Cytokines Interleukin-1 Beta (IL-1beta), IL-6, IL-8, IL-10, Tumor Necrosis Factor Alpha, and IL-12(p70) in Malian Children with Severe Plasmodium Falciparum Malaria and Matched Uncomplicated Malaria or Healthy...

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 2004 Sep 24

PMID 15385460

Citations 239

Authors

K E Lyke

R Burges

Y Cissoko

L Sangare

M Dao

I Diarra

A Kone

R Harley

C V Plowe

O K Doumbo

M B Sztein

Affiliations

Soon will be listed here.

Abstract

Inflammatory cytokines play an important role in human immune responses to malarial disease. However, the role of these mediators in disease pathogenesis, and the relationship between host protection and injury remains unclear. A total of 248 cases of severe Plasmodium falciparum malaria among children aged 3 months to 14 years residing in Bandiagara, Mali, were matched to cases of uncomplicated malaria and healthy controls. Using modified World Health Organization criteria for defining severe malaria, we identified 100 cases of cerebral malaria (coma, seizure, and obtundation), 17 cases of severe anemia (hemoglobin, <5 g/dl), 18 cases combined cerebral malaria with severe anemia, and 92 cases with hyperparasitemia (asexual trophozoites, >500,000/mm3). Significantly elevated levels (given as geometric mean concentrations in picograms/milliliter) of interleukin-6 (IL-6; 485.2 versus 54.1; P = <0.001), IL-10 (1,099.3 versus 14.1; P = <0.001), tumor necrosis factor alpha (10.1 versus 7.7; P = <0.001), and IL-12(p70) (48.9 versus 31.3; P = 0.004) in serum were found in severe cases versus healthy controls. Significantly elevated levels of IL-6 (485.2 versus 141.0; P = <0.001) and IL-10 (1,099.3 versus 133.9; P = <0.001) were seen in severe malaria cases versus uncomplicated malaria controls. Cerebral malaria was associated with significantly elevated levels of IL-6 (754.5 versus 311.4; P = <0.001) and IL-10 (1,405.6 versus 868.6; P = 0.006) compared to severe malaria cases without cerebral manifestations. Conversely, lower levels of IL-6 (199.2 versus 487.6; P = 0.03) and IL-10 (391.1 versus 1,160.9; P = 0.002) were noted in children with severe anemia compared to severe malaria cases with hemoglobin at >5 g/dl. Hyperparasitemia was associated with significantly lower levels of IL-6 (336.6 versus 602.1; P = 0.002). These results illustrate the complex relationships between inflammatory cytokines and disease in P. falciparum malaria.

Citing Articles

Apolipoprotein A1 Gene Polymorphism and Its Association With TNF-Alpha and Interleukin-6 Levels in Uncomplicated Plasmodium Falciparum Malaria in Nigerian Children.

Orimadegun B, Faneye A, Odaibo G, Falade C Am J Med Sci Med. 2025; 13(1):1-7.

PMID: 40061813 PMC: 11890195. DOI: 10.12691/ajmsm-13-1-1.

Stress-mediating inflammatory cytokine profiling reveals unique patterns in malaria and typhoid fever patients.

Bin Eric M, Netongo P, Kamdem S, Nzuno C, Tchoutang A, Berenger T PLoS One. 2025; 20(2):e0306585.

PMID: 40014608 PMC: 11867312. DOI: 10.1371/journal.pone.0306585.

The differential effect of Interferon-gamma on acute kidney injury and parasitemia in experimental malaria.

Sadler R, Possemiers H, Prenen F, Van Landschoot L, Pollenus E, Deckers M Sci Rep. 2025; 15(1):6402.

PMID: 39984601 PMC: 11845612. DOI: 10.1038/s41598-025-90473-7.

Clinical, immune and genetic risk factors of malaria-associated acute kidney injury in Zambian children: A study protocol.

Mwaba C, Munsaka S, Mwakazanga D, Rutagwerae D, Ngalamika O, Mwanza S PLoS One. 2025; 20(2):e0316205.

PMID: 39913368 PMC: 11801570. DOI: 10.1371/journal.pone.0316205.

An integrated approach to predict genetic risk for Mosquito-Borne diseases in the local Population of Tehsil Haripur, Khyber Pakhtunkhwa, Pakistan.

Basri R, Aqeel M, Awan F, Khan S, Obaid A, Parveen R Sci Rep. 2025; 15(1):3478.

PMID: 39875533 PMC: 11775262. DOI: 10.1038/s41598-025-88095-0.

References

OGarra A, Arai N . The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol. 2000; 10(12):542-50. DOI: 10.1016/s0962-8924(00)01856-0. View

Pestka S, Krause C, Sarkar D, Walter M, Shi Y, Fisher P . Interleukin-10 and related cytokines and receptors. Annu Rev Immunol. 2004; 22:929-79. DOI: 10.1146/annurev.immunol.22.012703.104622. View

Malaguarnera L, Pignatelli S, Simpore J, Malaguarnera M, Musumeci S . Plasma levels of interleukin-12 (IL-12), interleukin-18 (IL-18) and transforming growth factor beta (TGF-beta) in Plasmodium falciparum malaria. Eur Cytokine Netw. 2003; 13(4):425-30. View

Abrams E, Brown H, Chensue S, Turner G, Tadesse E, Lema V . Host response to malaria during pregnancy: placental monocyte recruitment is associated with elevated beta chemokine expression. J Immunol. 2003; 170(5):2759-64. DOI: 10.4049/jimmunol.170.5.2759. View

Jahiel R, Vilcek J, Nussenzweig R . Exogenous interferon protects mice against Plasmodium berghei malaria. Nature. 1970; 227(5265):1350-1. DOI: 10.1038/2271350a0. View

Finley R, Mackey L, Lambert P . Virulent P. berghei malaria: prolonged survival and decreased cerebral pathology in cell-dependent nude mice. J Immunol. 1982; 129(5):2213-8. View

Newsome F . Increased phagocytosis of non-parasitized red cells in Plasmodium berghei malaria. Ann Trop Med Parasitol. 1984; 78(3):323-5. DOI: 10.1080/00034983.1984.11811823. View

Ferreira A, Schofield L, Enea V, Schellekens H, van der Meide P, Collins W . Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon. Science. 1986; 232(4752):881-4. DOI: 10.1126/science.3085218. View

Schofield L, Ferreira A, Altszuler R, NUSSENZWEIG V, Nussenzweig R . Interferon-gamma inhibits the intrahepatocytic development of malaria parasites in vitro. J Immunol. 1987; 139(6):2020-5. View

10.

Clark I, Cowden W, Butcher G, Hunt N . Possible roles of tumor necrosis factor in the pathology of malaria. Am J Pathol. 1987; 129(1):192-9. PMC: 1899696. View

11.

Clark I, Hunt N, Butcher G, Cowden W . Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole. J Immunol. 1987; 139(10):3493-6. View

12.

Clark I, Chaudhri G . Tumour necrosis factor may contribute to the anaemia of malaria by causing dyserythropoiesis and erythrophagocytosis. Br J Haematol. 1988; 70(1):99-103. DOI: 10.1111/j.1365-2141.1988.tb02440.x. View

13.

Grau G, Taylor T, Molyneux M, Wirima J, Vassalli P, Hommel M . Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med. 1989; 320(24):1586-91. DOI: 10.1056/NEJM198906153202404. View

14.

Grau G, Heremans H, Piguet P, Pointaire P, Lambert P, Billiau A . Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. Proc Natl Acad Sci U S A. 1989; 86(14):5572-4. PMC: 297664. DOI: 10.1073/pnas.86.14.5572. View

15.

Kern P, Hemmer C, Van Damme J, Gruss H, Dietrich M . Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. Am J Med. 1989; 87(2):139-43. DOI: 10.1016/s0002-9343(89)80688-6. View

16.

Grau G, Piguet P, Vassalli P, Lambert P . Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data. Immunol Rev. 1989; 112:49-70. DOI: 10.1111/j.1600-065x.1989.tb00552.x. View

17.

Kwiatkowski D, Hill A, Sambou I, Twumasi P, Castracane J, Manogue K . TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet. 1990; 336(8725):1201-4. DOI: 10.1016/0140-6736(90)92827-5. View

18.

Shaffer N, Grau G, Hedberg K, Davachi F, Lyamba B, Hightower A . Tumor necrosis factor and severe malaria. J Infect Dis. 1991; 163(1):96-101. DOI: 10.1093/infdis/163.1.96. View

19.

Kwiatkowski D, Nowak M . Periodic and chaotic host-parasite interactions in human malaria. Proc Natl Acad Sci U S A. 1991; 88(12):5111-3. PMC: 51821. DOI: 10.1073/pnas.88.12.5111. View

20.

de Waal Malefyt R, Haanen J, Spits H, Roncarolo M, Te Velde A, Figdor C . Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med. 1991; 174(4):915-24. PMC: 2118975. DOI: 10.1084/jem.174.4.915. View